ATON-005

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameATON-005
Drug Alias NameATON-005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsPsychotic DisordersDiGeorge Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBausch Health Companies Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBausch Health Americas Inc
Active IndicationsN/A
Inactive IndicationsPsychotic DisordersDiGeorge Syndrome

Other Information

ATC CodeN/A
Related LinksN/A